Bicocca Open Archive

Logo unimib boa
CHIORAZZI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.586
EU - Europa 6.147
AS - Asia 2.300
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 15
AF - Africa 11
Totale 19.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.382
IT - Italia 1.270
DE - Germania 1.235
CN - Cina 1.157
SE - Svezia 926
IE - Irlanda 810
UA - Ucraina 518
RU - Federazione Russa 481
SG - Singapore 319
GB - Regno Unito 306
HK - Hong Kong 304
CA - Canada 196
VN - Vietnam 194
AT - Austria 138
FI - Finlandia 134
DK - Danimarca 113
FR - Francia 101
IN - India 84
ID - Indonesia 56
JP - Giappone 48
TR - Turchia 47
BE - Belgio 37
KR - Corea 34
NL - Olanda 26
EU - Europa 23
MY - Malesia 20
NZ - Nuova Zelanda 18
IR - Iran 17
AU - Australia 16
ES - Italia 10
BR - Brasile 9
TW - Taiwan 9
PL - Polonia 7
CZ - Repubblica Ceca 6
EG - Egitto 6
HR - Croazia 6
CH - Svizzera 5
MX - Messico 5
SA - Arabia Saudita 5
BG - Bulgaria 4
HU - Ungheria 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
PT - Portogallo 3
RO - Romania 3
GT - Guatemala 2
LB - Libano 2
NG - Nigeria 2
RS - Serbia 2
SC - Seychelles 2
AR - Argentina 1
CR - Costa Rica 1
EE - Estonia 1
KW - Kuwait 1
NO - Norvegia 1
PE - Perù 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 19.116
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.859
Dublin 789
Woodbridge 773
Chandler 772
Frankfurt am Main 738
Wilmington 634
Houston 576
Fairfield 565
Dearborn 547
Jacksonville 539
Milan 477
Ashburn 404
New York 370
Princeton 302
Hong Kong 272
Nanjing 232
Seattle 231
Boardman 179
Singapore 167
Cambridge 160
Shanghai 141
Vienna 138
Beijing 98
Dong Ket 92
Lachine 85
Guangzhou 84
Lawrence 78
Altamura 73
Nanchang 72
Shenyang 69
Jakarta 56
Andover 51
Falls Church 43
Hangzhou 41
Toronto 41
Pune 39
Jinan 38
San Diego 38
Ottawa 37
Fremont 36
Rome 36
Carate Brianza 35
Jiaxing 35
Helsinki 34
Kunming 34
Brussels 32
Tianjin 30
Changsha 29
Hebei 29
Zhengzhou 28
Nürnberg 27
Grafing 26
Norwalk 26
Los Angeles 25
Sacramento 24
Bergamo 22
Chicago 22
Shangdi 22
Mountain View 20
Ningbo 20
London 19
Edmonton 18
Phoenix 17
Taizhou 17
Leawood 16
Codroipo 15
Hefei 15
Lissone 15
Philadelphia 15
Tokyo 15
Florence 13
Mainz 13
Melzo 13
Pasir Mas 12
Shinjuku 12
Kiev 11
Washington 11
Bologna 10
Cagliari 10
Daejeon 10
Lappeenranta 10
Paris 10
Sesto San Giovanni 10
Wuhan 10
Changchun 9
Catania 8
Huizen 8
Canazei 7
Dallas 7
Desio 7
Fuzhou 7
San Mateo 7
Yongin-si 7
Auckland 6
Brno 6
Frederick 6
Haikou 6
Istanbul 6
Lanzhou 6
Melbourne 6
Totale 13.918
Salva come PNG Salva come JPEG
Nome #
Age-related changes in the function and structure of the peripheral sensory pathway in mice 289
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 281
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 277
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 265
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 260
Artificial apolipoprotein corona enables nanoparticle brain targeting 256
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 252
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 241
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 239
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 228
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 226
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 210
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 206
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 194
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 191
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 190
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 185
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 179
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 179
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 178
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 176
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 175
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 172
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 172
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 171
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 171
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 169
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 167
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 166
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 166
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 166
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 160
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 160
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 159
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 157
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 156
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 156
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 156
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 156
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 155
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 155
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 152
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 151
Lipoplatin tm: a less neurotoxic formulation of cisplatin 151
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 150
Current view in platinum drug mechanisms of peripheral neurotoxicity 150
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 150
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 149
OCT2 transporter involvement in development of cisplatin toxicity 149
Granulocytes in actively induced Lewis rat EAE 144
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 144
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 144
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 143
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 142
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 142
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 140
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 139
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 136
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 135
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 135
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 134
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 131
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 128
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 126
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 125
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 124
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 124
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 123
Multimodal experimental approach to the study of human neurological diseases 123
MSCs effect on Dark Agouti rats affected by chronic EAE 121
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 120
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 120
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 119
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 119
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 119
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 118
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 118
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 118
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 117
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 114
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 113
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 113
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 113
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 113
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 112
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 111
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 110
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 110
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 110
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 110
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 109
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 109
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 108
Genetic factors influencing the development of vincristine-induced neurotoxicity 108
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 107
Characterization of Glutamate Transporters in Peripheral Nervous System. 107
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 107
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 107
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 106
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity 106
Totale 15.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.243 0 226 226 202 338 455 593 248 334 319 247 55
2020/20213.424 147 132 377 353 262 306 408 321 290 258 204 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.484 389 846 380 332 259 540 63 181 277 51 104 62
2023/20242.986 97 98 101 146 386 725 508 163 158 68 68 468
2024/2025572 452 120 0 0 0 0 0 0 0 0 0 0
Totale 20.492